FDA inspection
Hubei Gedian Humanwell Pharmaceutical Co., Ltd.: FDA inspection ending Jun 28, 2019
FDA inspection 1098272 · Voluntary Action Indicated (VAI) · Ezhou
Key facts
| Inspection ID | 1098272 |
|---|---|
| Firm | Hubei Gedian Humanwell Pharmaceutical Co., Ltd. |
| FEI number | 3004117486 |
| Address | Gedian, Economic Development District |
| City | Ezhou |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Jun 28, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data